TrialTechnology in cancer research & treatment

EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer.

Fei Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.